Gastrodin Reduces Blood Pressure by Intervening with RAAS and PPARγ in SHRs

Table 1

Cardiac function (means ± SEM).

	IVS; d (mm)	IVS; s (mm)	LVID; d (mm)	LVID; s (mm)	LVPW; d (mm)	LVPW; s (mm)	EF (%)
WKY	1.29 ± 0.07	2.21 ± 0.29	6.35 ± 0.43	3.77 ± 0.58	1.64 ± 0.15	2.48 ± 0.16	69.95 ± 8.40
SHR	1.70 ± 0.18	2.33 ± 0.37	6.24 ± 0.80	4.42 ± 1.23	2.02 ± 0.26	2.41 ± 0.47	55.16 ± 17.32
GAS	1.53 ± 0.24	2.09 ± 0.22	6.73 ± 0.42	4.88 ± 0.49	1.87 ± 0.25	2.35 ± 0.21	51.95 ± 7.87

After 4-week treatment, there was no difference in cardiac function among the three groups.